End-stage renal disease reduction in drug utilization suggests bundled payment is too high /
Saved in:
Main Author: | Cosgrove, James C., |
---|---|
Other Authors: | United States. Government Accountability Office, |
Format: | eBook |
Language: | English |
Published: |
Washington, DC :
United States Government Accountability Office,
2012.
|
Physical Description: |
1 online resource (14 pages) : color illustration. |
Edition: | Revised. |
Subjects: | |
Online Access: |
https://purl.fdlp.gov/GPO/gpo33749 |
In Prospector
Similar Items
-
Department of Health and Human Services, Centers for Medicare and Medicaid Services Medicare program, change in methodology for determining payment for extraordinarily high-cost cases (cost outliers) under the acute care hospital inpatient and long-term care hospital prospective payment systems
by: United States. General Accounting Office.
Published: (2003) -
Medicare private sector initiatives to bundle hospital and physician payments for an episode of care
by: Cosgrove, James C.
Published: (2011) -
Update : Medicare payments for end stage renal disease drugs
by: United States. Department of Health and Human Services. Office of Inspector General,
Published: (2014) -
Medicare high-expenditure Part B drugs
by: Cosgrove, James C.
Published: (2012) -
Medicare coverage of end-stage renal disease (ESRD)
by: Kirchhoff, Suzanne M.,
Published: (2018)